Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John C. Ruckdeschel, MD
H. Lee Moffitt Cancer Center and Research Institute
Study Chair - Paul A. Bunn, MD
University of Colorado, Denver
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Allegheny University Hospitals- Hahnemann
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Oct 1995
- Primary completion
- 1 Oct 2004
- Completion
- 1 Oct 2004
- Last update posted
- 22 Jun 2023
- Registered enrollment
- 1,100
- Registry id
- NCT00002667
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.